Video

How Do Emerging Infectious Diseases Affect National Security and Policy Discussions?

Author(s):

Amesh Adalja, MD, UPMC Center for National Security and his colleagues study recent outbreaks and work on how to better prepare the country for outbreaks like this in the future.

Amesh Adalja, MD, UPMC Center for National Security and his colleagues study recent outbreaks and work on how to better prepare the country for outbreaks like this in the future. At IDWeek 2016, Adalja explained that his team looked at non-traditional approaches as in rather scrutinizing ordinary antibiotics when you have ore and more resistance, he was "thinking about changing the whole game and going into more specific targeted therapies". He wanted to look at what's the case for bacterial phages, and question how would one facilitate the use of those in clinical settings. "We're taking what's going on in the scientific world and bridging it into the clinical and policy worlds," said Adalja.

Related Videos
Ben Samelson-Jones,Ben Samelson-Jones, MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy
Françoise Bernaudin, MD: A Decade of Follow-up Reveals allo-SCT Superiority Over SOC for Sickle Cell Anemia
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Steven W. Pipe, MD: Fitusiran With Anti-Thrombin Modulation Yields Effective Bleed Control, Reduces Infusions
Caroline Piatek, MD: Improving Patient-Reported Outcomes in PNH With Danicopan Add-on Therapy
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
Jörn Schattenberg, MD | Credit: Novo Nordisk
Jörn Schattenberg, MD | Credit: Novo Nordisk
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
© 2024 MJH Life Sciences

All rights reserved.